Welcome to CDC Stacks | National Action Plan for Combating Multidrug-Resistant Tuberculosis : six–month progress report and future direction - 41770 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
National Action Plan for Combating Multidrug-Resistant Tuberculosis : six–month progress report and future direction
  • Published Date:
    9/27/16
  • Language:
    English
Filetype[PDF - 401.33 KB]


Details:
  • Corporate Authors:
    United States. Agency for International Development. ; Centers for Disease Control and Prevention (U.S.) ; National Institutes of Health (U.S.
  • Description:
    On December 22, 2015, the White House National Security Council officially released a plan to address multidrug-resistant tuberculosis (MDR-TB) domestically and internationally and to advance research on this critical public health issue through a National Action Plan for Combating MDR-TB (hereafter referred to as the NAP). The release was followed by a launch event on January 7, 2016, which was open to the general public. The NAP, which will build on the World Health Organization’s (WHO) END TB Strategy and the U.S. Government’s (USG) domestic and global tuberculosis (TB) strategies, will contribute to the success of these existing strategies.

    The US Centers for Disease Control and Prevention (CDC), the United States Agency for International Development (USAID) and the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes for Health (NIH) have worked together over the past six months to coordinate plans for achieving the objectives of the NAP, including agreement on roles and responsibilities and pathways for implementation of the NAP, and sharing lessons learned on NAP activities. Existing platforms are being utilized to expand and enhance activities to accomplish milestones in the short, medium and long term. In addition, USG agencies are also leveraging the investments of the Global Fund and domestic resources by providing technical assistance aimed at ensuring access to high-quality MDR-TB diagnosis, treatment and prevention services, and utilizing existing biomedical research funding mechanisms to advance product development and to drive innovation. The interagency group has met several times in person and maintains communication through monthly coordination calls and email updates. In May 2016, the Federal TB Task Force had an in-person meeting focused on research to highlight existing work and coordinate future activities that will contribute to achieving the NAP goals. One key result of this collaboration has been finalization of the monitoring and evaluation framework and initiation of baseline data collection for milestones. This progress report summarizes activities undertaken in support of the NAP during the first six months by Goal and Objective.

    Publication date from document properties.

    usg-mdr-napreport-2016-final.pdf

  • Document Type:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like: